Alabama's Cahaba Medical Care, a rural health clinic relying on federal Teaching Health Centers grants, faces uncertain future amid federal budget cuts and administrative changes, threatening essential healthcare access in underserved communities.

Federal layoffs at the Department of Health and Human Services have disrupted the World Trade Center Health Program, causing care delays for 9/11 survivors in New York City and raising concerns about program sustainability and local funding burdens.

Washington State introduces health and dental benefits for licensed family child care providers under SEIU 925 agreement, with eligibility tied to subsidy programs and SSPS payments.

Explore how Medicaid expansion and premium tax credits have driven historic improvements in U.S. health insurance coverage and the risks posed by potential policy changes.

The Supreme Court evaluates the constitutionality of the Affordable Care Act's preventive services mandate by assessing the U.S. Preventive Services Task Force's structure, with potential widespread impact on no-cost preventive coverage in American health insurance.

HCI Group, a NYSE-listed insurance holding company, announces its 2025 Annual Meeting of Shareholders and highlights its insurance operations and insurtech business, Exzeo Group.

CRC Group names Todd Jones as chief growth officer to drive strategic growth and client alignment, reinforcing its independent wholesale and underwriting market position amid a corporate rebrand.

Explore recent U.S. insurance developments covering AI use in underwriting, wildfire risk mapping, data security breaches in auto insurance, environmental health concerns, and regulatory actions affecting property and environmental risk insurance.

New research finds declining life insurance ownership and widespread financial inadequacy in American households, highlighting critical challenges for the U.S. insurance market and financial security planning.

April 2025 market update reveals insurer stock declines amid UnitedHealth earnings miss, offset by pharma gains led by Eli Lilly's drug innovation and strong healthcare sector earnings projections.